体外膜氧合维持治疗成人的低强度肝素方案与标准强度肝素方案:一项回顾性队列研究。

IF 1 Q4 PHARMACOLOGY & PHARMACY
Rachel C Robinson, Ashley N Taylor, Amy W Cato, Vijay S Patel, Jennifer L Waller, Nathaniel B Wayne
{"title":"体外膜氧合维持治疗成人的低强度肝素方案与标准强度肝素方案:一项回顾性队列研究。","authors":"Rachel C Robinson, Ashley N Taylor, Amy W Cato, Vijay S Patel, Jennifer L Waller, Nathaniel B Wayne","doi":"10.1177/08971900241285248","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Patients maintained on extracorporeal membrane oxygenation (ECMO) often require systemic anticoagulation to prevent circuit clotting and systemic thromboembolic complications. The optimal intensity of anticoagulation to balance the risk of bleeding and prevention of thrombotic complications in this patient population is not well described. <b>Objective:</b> To compare bleeding events in patients on ECMO anticoagulated with standard vs low intensity heparin protocols. <b>Methods:</b> This single-center, retrospective cohort study included adult patients on VA- or VV-ECMO and anticoagulated with low or standard intensity heparin protocols. The primary outcome was the incidence of major bleeding; secondary outcomes included the incidence of minor bleeding, thrombotic complications, heparin-induced thrombocytopenia, in-hospital mortality, time in therapeutic range, anti-Xa correlation with aPTT, intensive care unit and hospital lengths of stay, oxygenator exchanges, and rate of protocol switching. <b>Results:</b> A total of 27 patients (14 low intensity, 13 standard intensity) were included. There were six major bleeding events in the low intensity group and four in the standard intensity group (<i>P</i> = 0.69); there were four minor bleeding events in the low intensity group and five in the standard intensity group (<i>P</i> = 0.69). Seven patients in the standard intensity group switched protocols; zero patients in the low intensity group switched protocols (<i>P</i> = 0.002). There were no differences in any other outcomes. <b>Conclusions:</b> There was no difference in the incidence of any bleeding or thrombotic events when using a low vs standard intensity heparin protocol in patients on ECMO. A low intensity heparin strategy for patients on ECMO may be feasible and safe.</p>","PeriodicalId":16818,"journal":{"name":"Journal of pharmacy practice","volume":" ","pages":"8971900241285248"},"PeriodicalIF":1.0000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study.\",\"authors\":\"Rachel C Robinson, Ashley N Taylor, Amy W Cato, Vijay S Patel, Jennifer L Waller, Nathaniel B Wayne\",\"doi\":\"10.1177/08971900241285248\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Patients maintained on extracorporeal membrane oxygenation (ECMO) often require systemic anticoagulation to prevent circuit clotting and systemic thromboembolic complications. The optimal intensity of anticoagulation to balance the risk of bleeding and prevention of thrombotic complications in this patient population is not well described. <b>Objective:</b> To compare bleeding events in patients on ECMO anticoagulated with standard vs low intensity heparin protocols. <b>Methods:</b> This single-center, retrospective cohort study included adult patients on VA- or VV-ECMO and anticoagulated with low or standard intensity heparin protocols. The primary outcome was the incidence of major bleeding; secondary outcomes included the incidence of minor bleeding, thrombotic complications, heparin-induced thrombocytopenia, in-hospital mortality, time in therapeutic range, anti-Xa correlation with aPTT, intensive care unit and hospital lengths of stay, oxygenator exchanges, and rate of protocol switching. <b>Results:</b> A total of 27 patients (14 low intensity, 13 standard intensity) were included. There were six major bleeding events in the low intensity group and four in the standard intensity group (<i>P</i> = 0.69); there were four minor bleeding events in the low intensity group and five in the standard intensity group (<i>P</i> = 0.69). Seven patients in the standard intensity group switched protocols; zero patients in the low intensity group switched protocols (<i>P</i> = 0.002). There were no differences in any other outcomes. <b>Conclusions:</b> There was no difference in the incidence of any bleeding or thrombotic events when using a low vs standard intensity heparin protocol in patients on ECMO. A low intensity heparin strategy for patients on ECMO may be feasible and safe.</p>\",\"PeriodicalId\":16818,\"journal\":{\"name\":\"Journal of pharmacy practice\",\"volume\":\" \",\"pages\":\"8971900241285248\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmacy practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/08971900241285248\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08971900241285248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:体外膜肺氧合(ECMO)患者通常需要全身抗凝治疗,以防止回路凝血和全身血栓栓塞并发症。目前尚不清楚在这类患者中平衡出血风险和预防血栓并发症的最佳抗凝强度。研究目的比较使用标准与低强度肝素方案抗凝的 ECMO 患者的出血事件。方法:这项单中心回顾性队列研究纳入了接受 VA- 或 VV-ECMO 并使用低强度或标准强度肝素方案进行抗凝的成年患者。主要结果是大出血的发生率;次要结果包括轻微出血的发生率、血栓并发症、肝素诱导的血小板减少症、院内死亡率、治疗范围内的时间、抗 Xa 与 aPTT 的相关性、重症监护室和住院时间、氧合机交换次数以及方案转换率。结果:共纳入 27 名患者(14 名低浓度患者,13 名标准强度患者)。低强度组有 6 例大出血,标准强度组有 4 例(P = 0.69);低强度组有 4 例轻微出血,标准强度组有 5 例(P = 0.69)。标准强度组有 7 名患者更换了治疗方案;低强度组没有患者更换治疗方案(P = 0.002)。其他结果无差异。结论在 ECMO 患者中使用低强度肝素方案与标准强度肝素方案时,任何出血或血栓事件的发生率均无差异。对 ECMO 患者采用低强度肝素策略可能是可行且安全的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study.

Background: Patients maintained on extracorporeal membrane oxygenation (ECMO) often require systemic anticoagulation to prevent circuit clotting and systemic thromboembolic complications. The optimal intensity of anticoagulation to balance the risk of bleeding and prevention of thrombotic complications in this patient population is not well described. Objective: To compare bleeding events in patients on ECMO anticoagulated with standard vs low intensity heparin protocols. Methods: This single-center, retrospective cohort study included adult patients on VA- or VV-ECMO and anticoagulated with low or standard intensity heparin protocols. The primary outcome was the incidence of major bleeding; secondary outcomes included the incidence of minor bleeding, thrombotic complications, heparin-induced thrombocytopenia, in-hospital mortality, time in therapeutic range, anti-Xa correlation with aPTT, intensive care unit and hospital lengths of stay, oxygenator exchanges, and rate of protocol switching. Results: A total of 27 patients (14 low intensity, 13 standard intensity) were included. There were six major bleeding events in the low intensity group and four in the standard intensity group (P = 0.69); there were four minor bleeding events in the low intensity group and five in the standard intensity group (P = 0.69). Seven patients in the standard intensity group switched protocols; zero patients in the low intensity group switched protocols (P = 0.002). There were no differences in any other outcomes. Conclusions: There was no difference in the incidence of any bleeding or thrombotic events when using a low vs standard intensity heparin protocol in patients on ECMO. A low intensity heparin strategy for patients on ECMO may be feasible and safe.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of pharmacy practice
Journal of pharmacy practice PHARMACOLOGY & PHARMACY-
CiteScore
3.20
自引率
7.70%
发文量
184
期刊介绍: The Journal of Pharmacy Practice offers the practicing pharmacist topical, important, and useful information to support pharmacy practice and pharmaceutical care and expand the pharmacist"s professional horizons. The journal is presented in a single-topic, scholarly review format. Guest editors are selected for expertise in the subject area, who then recruit contributors from that practice or topic area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信